img

Global Insulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Insulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Insulin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insulin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Short Acting and Intermediate Acting are the major drivers for the industry.
The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Segment by Type
Animal Insulin
Regular Human Insulin
Insulin Analogue

Segment by Application


Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insulin introduction, etc. Insulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Insulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Insulin Market Overview
1.1 Insulin Product Overview
1.2 Insulin Market Segment by Type
1.2.1 Animal Insulin
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Global Insulin Market Size by Type
1.3.1 Global Insulin Market Size Overview by Type (2018-2034)
1.3.2 Global Insulin Historic Market Size Review by Type (2018-2024)
1.3.3 Global Insulin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Sales Breakdown by Type (2018-2024)
1.4.2 Europe Insulin Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Insulin Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Insulin Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Insulin Sales Breakdown by Type (2018-2024)
2 Global Insulin Market Competition by Company
2.1 Global Top Players by Insulin Sales (2018-2024)
2.2 Global Top Players by Insulin Revenue (2018-2024)
2.3 Global Top Players by Insulin Price (2018-2024)
2.4 Global Top Manufacturers Insulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Market Competitive Situation and Trends
2.5.1 Insulin Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Market
2.8 Key Manufacturers Insulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Status and Outlook by Region
3.1 Global Insulin Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Insulin Historic Market Size by Region
3.2.1 Global Insulin Sales in Volume by Region (2018-2024)
3.2.2 Global Insulin Sales in Value by Region (2018-2024)
3.2.3 Global Insulin Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Insulin Forecasted Market Size by Region
3.3.1 Global Insulin Sales in Volume by Region (2024-2034)
3.3.2 Global Insulin Sales in Value by Region (2024-2034)
3.3.3 Global Insulin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Insulin by Application
4.1 Insulin Market Segment by Application
4.1.1 Short Acting
4.1.2 Intermediate Acting
4.1.3 Long Acting
4.1.4 Pre-Mix Insulin
4.2 Global Insulin Market Size by Application
4.2.1 Global Insulin Market Size Overview by Application (2018-2034)
4.2.2 Global Insulin Historic Market Size Review by Application (2018-2024)
4.2.3 Global Insulin Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Sales Breakdown by Application (2018-2024)
4.3.2 Europe Insulin Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Insulin Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Insulin Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Insulin Sales Breakdown by Application (2018-2024)
5 North America Insulin by Country
5.1 North America Insulin Historic Market Size by Country
5.1.1 North America Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Insulin Sales in Volume by Country (2018-2024)
5.1.3 North America Insulin Sales in Value by Country (2018-2024)
5.2 North America Insulin Forecasted Market Size by Country
5.2.1 North America Insulin Sales in Volume by Country (2024-2034)
5.2.2 North America Insulin Sales in Value by Country (2024-2034)
6 Europe Insulin by Country
6.1 Europe Insulin Historic Market Size by Country
6.1.1 Europe Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Insulin Sales in Volume by Country (2018-2024)
6.1.3 Europe Insulin Sales in Value by Country (2018-2024)
6.2 Europe Insulin Forecasted Market Size by Country
6.2.1 Europe Insulin Sales in Volume by Country (2024-2034)
6.2.2 Europe Insulin Sales in Value by Country (2024-2034)
7 Asia-Pacific Insulin by Region
7.1 Asia-Pacific Insulin Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Insulin Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Insulin Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Insulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Insulin Sales in Value by Region (2024-2034)
8 Latin America Insulin by Country
8.1 Latin America Insulin Historic Market Size by Country
8.1.1 Latin America Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Insulin Sales in Volume by Country (2018-2024)
8.1.3 Latin America Insulin Sales in Value by Country (2018-2024)
8.2 Latin America Insulin Forecasted Market Size by Country
8.2.1 Latin America Insulin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Insulin Sales in Value by Country (2024-2034)
9 Middle East and Africa Insulin by Country
9.1 Middle East and Africa Insulin Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Insulin Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Insulin Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Insulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Insulin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novo Nordisk Insulin Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Eli Lilly Insulin Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Sanofi-Aventis
10.3.1 Sanofi-Aventis Company Information
10.3.2 Sanofi-Aventis Introduction and Business Overview
10.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi-Aventis Insulin Products Offered
10.3.5 Sanofi-Aventis Recent Development
10.4 Tonghua Dongbao
10.4.1 Tonghua Dongbao Company Information
10.4.2 Tonghua Dongbao Introduction and Business Overview
10.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Tonghua Dongbao Insulin Products Offered
10.4.5 Tonghua Dongbao Recent Development
10.5 Ganlee
10.5.1 Ganlee Company Information
10.5.2 Ganlee Introduction and Business Overview
10.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Ganlee Insulin Products Offered
10.5.5 Ganlee Recent Development
10.6 United Laboratory
10.6.1 United Laboratory Company Information
10.6.2 United Laboratory Introduction and Business Overview
10.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2018-2024)
10.6.4 United Laboratory Insulin Products Offered
10.6.5 United Laboratory Recent Development
10.7 Jiangsu Wanbang
10.7.1 Jiangsu Wanbang Company Information
10.7.2 Jiangsu Wanbang Introduction and Business Overview
10.7.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Jiangsu Wanbang Insulin Products Offered
10.7.5 Jiangsu Wanbang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Industrial Chain Analysis
11.4 Insulin Market Dynamics
11.4.1 Insulin Industry Trends
11.4.2 Insulin Market Drivers
11.4.3 Insulin Market Challenges
11.4.4 Insulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Distributors
12.3 Insulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Animal Insulin
Table 2. Major Company of Regular Human Insulin
Table 3. Major Company of Insulin Analogue
Table 4. Global Insulin Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Insulin Sales by Type (2018-2024) & (K MT)
Table 6. Global Insulin Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Insulin Sales by Type (2018-2024) & (US& Million)
Table 8. Global Insulin Market Share in Value by Type (2018-2024)
Table 9. Global Insulin Price by Type (2018-2024) & (USD/MT)
Table 10. Global Insulin Sales by Type (2024-2034) & (K MT)
Table 11. Global Insulin Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Insulin Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Insulin Sales Market Share in Value by Type (2024-2034)
Table 14. Global Insulin Price by Type (2024-2034) & (USD/MT)
Table 15. North America Insulin Sales by Type (2018-2024) & (K MT)
Table 16. North America Insulin Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Insulin Sales (K MT) by Type (2018-2024)
Table 18. Europe Insulin Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Insulin Sales (K MT) by Type (2018-2024)
Table 20. Asia-Pacific Insulin Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Insulin Sales (K MT) by Type (2018-2024)
Table 22. Latin America Insulin Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Insulin Sales (K MT) by Type (2018-2024)
Table 24. Middle East and Africa Insulin Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Insulin Sales by Company (2018-2024) & (K MT)
Table 26. Global Insulin Sales Share by Company (2018-2024)
Table 27. Global Insulin Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Insulin Revenue Share by Company (2018-2024)
Table 29. Global Market Insulin Price by Company (2018-2024) & (USD/MT)
Table 30. Global Insulin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin as of 2022)
Table 33. Date of Key Manufacturers Enter into Insulin Market
Table 34. Key Manufacturers Insulin Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Insulin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Insulin Sales by Region (2018-2024) & (K MT)
Table 38. Global Insulin Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Insulin Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Insulin Sales Market Share in Value by Region (2018-2024)
Table 41. Global Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 42. Global Insulin Sales by Region (2024-2034) & (K MT)
Table 43. Global Insulin Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Insulin Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Insulin Sales Market Share in Value by Region (2024-2034)
Table 46. Global Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 47. Global Insulin Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Insulin Sales by Application (2018-2024) & (K MT)
Table 49. Global Insulin Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Insulin Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Insulin Sales Market Share in Value by Application (2018-2024)
Table 52. Global Insulin Price by Application (2018-2024) & (USD/MT)
Table 53. Global Insulin Sales by Application (2024-2034) & (K MT)
Table 54. Global Insulin Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Insulin Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Insulin Sales Market Share in Value by Application (2024-2034)
Table 57. Global Insulin Price by Application (2024-2034) & (USD/MT)
Table 58. North America Insulin Sales by Application (2018-2024) (K MT)
Table 59. North America Insulin Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Insulin Sales by Application (2018-2024) (K MT)
Table 61. Europe Insulin Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Insulin Sales by Application (2018-2024) (K MT)
Table 63. Asia-Pacific Insulin Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Insulin Sales by Application (2018-2024) (K MT)
Table 65. Latin America Insulin Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Insulin Sales by Application (2018-2024) (K MT)
Table 67. Middle East and Africa Insulin Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Insulin Sales by Country (2018-2024) & (K MT)
Table 69. North America Insulin Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Insulin Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Insulin Sales Market Share in Value by Country (2018-2024)
Table 72. North America Insulin Sales by Country (2024-2034) & (K MT)
Table 73. North America Insulin Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Insulin Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Insulin Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Insulin Sales by Country (2018-2024) & (K MT)
Table 77. Europe Insulin Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Insulin Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Insulin Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Insulin Sales by Country (2024-2034) & (K MT)
Table 81. Europe Insulin Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Insulin Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Insulin Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Insulin Sales by Region (2018-2024) & (K MT)
Table 85. Asia-Pacific Insulin Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Insulin Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Insulin Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Insulin Sales by Region (2024-2034) & (K MT)
Table 89. Asia-Pacific Insulin Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Insulin Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Insulin Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Insulin Sales by Country (2018-2024) & (K MT)
Table 93. Latin America Insulin Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Insulin Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Insulin Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Insulin Sales by Country (2024-2034) & (K MT)
Table 97. Latin America Insulin Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Insulin Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Insulin Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Insulin Sales by Country (2018-2024) & (K MT)
Table 101. Middle East and Africa Insulin Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Insulin Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Insulin Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Insulin Sales by Country (2024-2034) & (K MT)
Table 105. Middle East and Africa Insulin Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Insulin Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Insulin Sales Market Share in Value by Country (2024-2034)
Table 108. Novo Nordisk Company Information
Table 109. Novo Nordisk Introduction and Business Overview
Table 110. Novo Nordisk Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. Novo Nordisk Insulin Product
Table 112. Novo Nordisk Recent Development
Table 113. Eli Lilly Company Information
Table 114. Eli Lilly Introduction and Business Overview
Table 115. Eli Lilly Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Eli Lilly Insulin Product
Table 117. Eli Lilly Recent Development
Table 118. Sanofi-Aventis Company Information
Table 119. Sanofi-Aventis Introduction and Business Overview
Table 120. Sanofi-Aventis Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Sanofi-Aventis Insulin Product
Table 122. Sanofi-Aventis Recent Development
Table 123. Tonghua Dongbao Company Information
Table 124. Tonghua Dongbao Introduction and Business Overview
Table 125. Tonghua Dongbao Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Tonghua Dongbao Insulin Product
Table 127. Tonghua Dongbao Recent Development
Table 128. Ganlee Company Information
Table 129. Ganlee Introduction and Business Overview
Table 130. Ganlee Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Ganlee Insulin Product
Table 132. Ganlee Recent Development
Table 133. United Laboratory Company Information
Table 134. United Laboratory Introduction and Business Overview
Table 135. United Laboratory Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. United Laboratory Insulin Product
Table 137. United Laboratory Recent Development
Table 138. Jiangsu Wanbang Company Information
Table 139. Jiangsu Wanbang Introduction and Business Overview
Table 140. Jiangsu Wanbang Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. Jiangsu Wanbang Insulin Product
Table 142. Jiangsu Wanbang Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Insulin Market Trends
Table 146. Insulin Market Drivers
Table 147. Insulin Market Challenges
Table 148. Insulin Market Restraints
Table 149. Insulin Distributors List
Table 150. Insulin Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Product Picture
Figure 2. Global Insulin Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Insulin Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Insulin Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Animal Insulin
Figure 6. Global Animal Insulin Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Regular Human Insulin
Figure 8. Global Regular Human Insulin Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Insulin Analogue
Figure 10. Global Insulin Analogue Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Global Insulin Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Insulin Sales Market Share by Type in 2022 & 2034
Figure 13. North America Insulin Sales Market Share in Volume by Type in 2022
Figure 14. North America Insulin Sales Market Share in Value by Type in 2022
Figure 15. Europe Insulin Sales Market Share in Volume by Type in 2022
Figure 16. Europe Insulin Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Insulin Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Insulin Sales Market Share in Value by Type in 2022
Figure 19. Latin America Insulin Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Insulin Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Insulin Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Insulin Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Revenue in 2022
Figure 25. Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Short Acting
Figure 27. Global Short Acting Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Intermediate Acting
Figure 29. Global Intermediate Acting Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Long Acting
Figure 31. Global Long Acting Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Pre-Mix Insulin
Figure 33. Global Pre-Mix Insulin Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Global Insulin Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Insulin Sales Market Share by Application in 2022 & 2034
Figure 36. North America Insulin Sales Market Share in Volume by Application in 2022
Figure 37. North America Insulin Sales Market Share in Value by Application in 2022
Figure 38. Europe Insulin Sales Market Share in Volume by Application in 2022
Figure 39. Europe Insulin Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Insulin Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Insulin Sales Market Share in Value by Application in 2022
Figure 42. Latin America Insulin Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Insulin Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Insulin Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Insulin Manufacturing Cost Structure
Figure 47. Insulin Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed